Cargando…
The REST Gene Signature Predicts Drug Sensitivity in Neuroblastoma Cell Lines and Is Significantly Associated with Neuroblastoma Tumor Stage
Neuroblastoma is the most common and deadly solid tumor in children, and there is currently no effective treatment available for neuroblastoma patients. The repressor element-1 silencing transcription (REST) factor has been found to play important roles in the regulation of neural differentiation an...
Autores principales: | Liang, Jianfeng, Tong, Pan, Zhao, Wanni, Li, Yaqiao, Zhang, Li, Xia, Ying, Yu, Yanbing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139778/ https://www.ncbi.nlm.nih.gov/pubmed/24968265 http://dx.doi.org/10.3390/ijms150711220 |
Ejemplares similares
-
Correlation between the International Neuroblastoma Pathology Classification and genomic signature in neuroblastoma
por: Nakazawa, Atsuko, et al.
Publicado: (2015) -
An expression based REST signature predicts patient survival and therapeutic response for glioblastoma multiforme
por: Liang, Jianfeng, et al.
Publicado: (2016) -
The Significance of Lymphocytic Infiltration in Neuroblastoma
por: Lauder, I., et al.
Publicado: (1972) -
Serum Protein N-Glycosylation Signatures of Neuroblastoma
por: Qin, Wenjun, et al.
Publicado: (2021) -
Establishment and Validation of a Prognostic Immune Signature in Neuroblastoma
por: Yu, Yunhu, et al.
Publicado: (2021)